Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
Pending
verification pending
Revenue YoY
—
reported change
EBITDA
Pending
latest reported figure
Source
bse pending
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Foods and Inns reported a steady Q3 FY26 with flat sales tonnage due to deferred US call-offs amid tariff uncertainty. Frozen food volumes grew 35% YoY, driven by value-added products and two new airline customers. Revenue was impacted by lower realizations from pass-through of lower raw material costs. Management guided for a strong Q4, expecting PLI incentives (similar to last year's ~₹25cr) and improved profitability. The pectin project is progressing slowly with commercial orders expected from Q1 FY27. Risks include tariff volatility (US mango pulp at 25%, frozen at 50% pending reduction) and delayed tomato crop impacting Q4 sales. Debt stood at ₹460cr (₹50cr long-term), with working capital elevated due to non-mango inventory buildup.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects Q4 EBITDA to be better than last year, driven by higher volumes and PLI income.
- PLI claim submitted; expected disbursement soon; amount likely similar or slightly higher than FY25's ₹25cr.
- Construction started; expected completion in 9 months.
- Major customers likely to start commercial supply from Q1 FY27; 70-75% capacity utilization expected next year.
Risks flagged
- Mango pulp tariff at 25%, frozen at 50% pending reduction; customers delayed call-offs, impacting Q3 volumes.
- Tomato procurement started late; management unable to quantify order book, raising uncertainty about Q4 revenue.
- Total debt at ₹460cr, with working capital of ~₹410cr due to inventory buildup; interest costs remain elevated.
- Commercialization taking longer than expected; no revenue yet; management cites long customer testing cycles.
Key quotes
- We are internally looking at anywhere between 10 to 15% growth on EBITDA as well as gross margin on a minimum basis on a year-on-year basis. That's the internal targets that we have but that's not a guidance.
- Our Q4 is supposed to be one of our stellar quarters historically. That's been how the business has actually performed.
- Pectin is a gamechanger for us because waste to wealth is what everybody is talking and we are also in the similar line.
Research modules